In this regard, an abnormal expression of SNHG16 has been observed in multiple cancers and usually correlates with worse pathological features (69), while the novel lncRNA LINC01106 has been recently reported to be related to the overall survival of CRC patients by acting as inflammatory mediator in inflammatory bowel disease (IBD)-related CRC. This evidence concerns the gene SNHG16 and inflammatory bowel disease.